<

NICOX (EPA:COX) Bausch Health Announces Vyzulta® (latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved in South Korea

Transparency directive : regulatory news

09/02/2021 07:30



Other stories

28/03/2024 18:00
28/03/2024 12:25
28/03/2024 15:31
28/03/2024 21:54
28/03/2024 20:49
28/03/2024 12:08
28/03/2024 17:03
28/03/2024 20:53
28/03/2024 13:48
28/03/2024 20:14
28/03/2024 20:23
28/03/2024 17:37
28/03/2024 14:54
28/03/2024 17:48
28/03/2024 20:28
28/03/2024 20:51
28/03/2024 19:01
28/03/2024 09:59
27/03/2024 22:31
27/03/2024 15:06
27/03/2024 15:52
27/03/2024 19:23
28/03/2024 21:31
28/03/2024 19:00
28/03/2024 17:15
28/03/2024 13:11
28/03/2024 19:55
28/03/2024 19:31
28/03/2024 17:34
28/03/2024 20:41
27/03/2024 21:46
28/03/2024 17:55
27/03/2024 13:40
28/03/2024 17:23
28/03/2024 13:25
28/03/2024 12:57
28/03/2024 16:44
28/03/2024 02:42